Patents by Inventor Stuart J. Updike

Stuart J. Updike has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • DEVICE AND METHOD FOR DETERMINING ANALYTE LEVELS
    Publication number: 20130310666
    Abstract: Devices and methods for determining analyte levels are described. The devices and methods allow for the implantation of analyte-monitoring devices, such as glucose monitoring devices that result in the delivery of a dependable flow of blood to deliver sample to the implanted device. The devices include unique architectural arrangement in the sensor region that allows accurate data to be obtained over long periods of time.
    Type: Application
    Filed: July 23, 2013
    Publication date: November 21, 2013
    Applicant: DexCom, Inc.
    Inventors: Mark C. Shults, Stuart J. Updike, Rathbun K Rhodes, Barbara J. Gilligan, Mark A. Tapsak
  • Device and method for determining analyte levels
    Patent number: 8527026
    Abstract: Devices and methods for determining analyte levels are described. The devices and methods allow for the implantation of analyte-monitoring devices, such as glucose monitoring devices that result in the delivery of a dependable flow of blood to deliver sample to the implanted device. The devices include unique architectural arrangement in the sensor region that allows accurate data to be obtained over long periods of time.
    Type: Grant
    Filed: March 2, 2012
    Date of Patent: September 3, 2013
    Assignee: DexCom, Inc.
    Inventors: Mark C. Shults, Stuart J. Updike, Rathbun K. Rhodes, Barbara J. Gilligan, Mark A. Tapsak
  • Device and method for determining analyte levels
    Patent number: 8527025
    Abstract: Devices and methods for determining analyte levels are described. The devices and methods allow for the implantation of analyte-monitoring devices, such as glucose monitoring devices, that result in the delivery of a dependable flow of blood to deliver sample to the implanted device. The devices comprise a unique microarchitectural arrangement in the sensor region that allows accurate data to be obtained over long periods of time.
    Type: Grant
    Filed: November 22, 1999
    Date of Patent: September 3, 2013
    Assignee: DexCom, Inc.
    Inventors: Mark C. Shults, Stuart J. Updike, Rathbun K. Rhodes
  • DEVICE AND METHOD FOR DETERMINING ANALYTE LEVELS
    Publication number: 20120179014
    Abstract: Devices and methods for determining analyte levels are described. The devices and methods allow for the implantation of analyte-monitoring devices, such as glucose monitoring devices that result in the delivery of a dependable flow of blood to deliver sample to the implanted device. The devices include unique architectural arrangement in the sensor region that allows accurate data to be obtained over long periods of time.
    Type: Application
    Filed: March 2, 2012
    Publication date: July 12, 2012
    Applicant: DexCom, Inc.
    Inventors: Mark C. Shults, Stuart J. Updike, Rathbun K. Rhodes, Barbara J. Gilligan, Mark A. Tapsak
  • Device and method for determining analyte levels
    Patent number: 8155723
    Abstract: Devices and methods for determining analyte levels are described. The devices and methods allow for the implantation of analyte-monitoring devices, such as glucose monitoring devices that result in the delivery of a dependable flow of blood to deliver sample to the implanted device. The devices include unique architectural arrangement in the sensor region that allows accurate data to be obtained over long periods of time.
    Type: Grant
    Filed: January 28, 2010
    Date of Patent: April 10, 2012
    Assignee: DexCom, Inc.
    Inventors: Mark C. Shults, Stuart J. Updike, Rathbun K. Rhodes, Barbara J. Gilligan, Mark A. Tapsak
  • DEVICE AND METHOD FOR DETERMINING ANALYTE LEVELS
    Publication number: 20110253533
    Abstract: Devices and methods for determining analyte levels are described. The devices and methods allow for the implantation of analyte-monitoring devices, such as glucose monitoring devices, that result in the delivery of a dependable flow of blood to deliver sample to the implanted device. The devices comprise a unique microarchitectural arrangement in the sensor region that allows accurate data to be obtained over long periods of time.
    Type: Application
    Filed: June 22, 2011
    Publication date: October 20, 2011
    Applicant: DexCom, Inc.
    Inventors: Mark C. Shults, Stuart J. Updike, Rathbun K. Rhodes
  • Device and method for determining analyte levels
    Patent number: 7974672
    Abstract: Devices and methods for determining analyte levels are described. The devices and methods allow for the implantation of analyte-monitoring devices, such as glucose monitoring devices, that result in the delivery of a dependable flow of blood to deliver sample to the implanted device. The devices comprise a unique microarchitectural arrangement in the sensor region that allows accurate data to be obtained over long periods of time.
    Type: Grant
    Filed: April 19, 2010
    Date of Patent: July 5, 2011
    Assignee: DexCom, Inc.
    Inventors: Mark C. Shults, Stuart J. Updike, Rathbun K. Rhodes
  • Device and method for determining analyte levels
    Patent number: 7970448
    Abstract: Devices and methods for determining analyte levels are described. The devices and methods allow for the implantation of analyte-monitoring devices, such as glucose monitoring devices, that result in the delivery of a dependable flow of blood to deliver sample to the implanted device. The devices comprise a unique microarchitectural arrangement in the sensor region that allows accurate data to be obtained over long periods of time.
    Type: Grant
    Filed: April 19, 2010
    Date of Patent: June 28, 2011
    Assignee: DexCom, Inc.
    Inventors: Mark C. Shults, Stuart J. Updike, Rathbun K. Rhodes
  • LOW OXYGEN IN VIVO ANALYTE SENSOR
    Publication number: 20110144465
    Abstract: The present invention relates generally to systems and methods for measuring an analyte in a host. More particularly, the present invention relates to systems and methods for transcutaneous and subcutaneous measurement of glucose in a host.
    Type: Application
    Filed: February 18, 2011
    Publication date: June 16, 2011
    Applicant: DexCom, Inc.
    Inventors: Mark C. Shults, Rathburn K. Rhodes, Stuart J. Updike, James H. Brauker
  • Low oxygen in vivo analyte sensor
    Patent number: 7901354
    Abstract: The present invention relates generally to systems and methods for measuring an analyte in a host. More particularly, the present invention relates to systems and methods for transcutaneous and subcutaneous measurement of glucose in a host.
    Type: Grant
    Filed: May 1, 2008
    Date of Patent: March 8, 2011
    Assignee: DexCom, Inc.
    Inventors: Mark C. Shults, Rathbun K. Rhodes, Stuart J. Updike, James H. Brauker
  • Low oxygen in vivo analyte sensor
    Patent number: 7899511
    Abstract: The present invention relates generally to systems and methods for measuring an analyte in a host. More particularly, the present invention relates to systems and methods for transcutaneous and subcutaneous measurement of glucose in a host.
    Type: Grant
    Filed: January 17, 2006
    Date of Patent: March 1, 2011
    Assignee: DexCom, Inc.
    Inventors: Mark C. Shults, Rathburn K. Rhodes, Stuart J. Updike, James H. Brauker
  • Analyte measuring device
    Patent number: 7860545
    Abstract: An implantable analyte-measuring device including a membrane adapted to promote vascularization and/or interfere with barrier cell layer formation. The membrane includes any combination of materials, architecture, and bioactive agents that facilitate analyte transport to provide long-term in vivo performance of the implantable analyte-measuring device.
    Type: Grant
    Filed: February 26, 2008
    Date of Patent: December 28, 2010
    Assignee: DexCom, Inc.
    Inventors: Mark C. Shults, James H. Brauker, Victoria Carr-Brendel, Mark A. Tapsak, Dubravka Markovic, Stuart J. Updike, Rathbun K. Rhodes
  • Device and method for determining analyte levels
    Patent number: 7835777
    Abstract: Devices and methods for determining analyte levels are described. The devices and methods allow for the implantation of analyte-monitoring devices, such as glucose monitoring devices, that result in the delivery of a dependable flow of blood to deliver sample to the implanted device. The devices comprise a unique microarchitectural arrangement in the sensor region that allows accurate data to be obtained over long periods of time.
    Type: Grant
    Filed: December 22, 2009
    Date of Patent: November 16, 2010
    Assignee: DexCom, Inc.
    Inventors: Mark C. Shults, Stuart J. Updike, Rathbun K. Rhodes
  • Device and method for determining analyte levels
    Patent number: 7792562
    Abstract: Devices and methods for determining analyte levels are described. The devices and methods allow for the implantation of analyte-monitoring devices, such as glucose monitoring devices, that result in the delivery of a dependable flow of blood to deliver sample to the implanted device. The devices comprise a unique microarchitectural arrangement in the sensor region that allows accurate data to be obtained over long periods of time.
    Type: Grant
    Filed: December 22, 2009
    Date of Patent: September 7, 2010
    Assignee: DexCom, Inc.
    Inventors: Mark C. Shults, Stuart J. Updike, Rathbun K. Rhodes
  • DEVICE AND METHOD FOR DETERMINING ANALYTE LEVELS
    Publication number: 20100204559
    Abstract: Devices and methods for determining analyte levels are described. The devices and methods allow for the implantation of analyte-monitoring devices, such as glucose monitoring devices, that result in the delivery of a dependable flow of blood to deliver sample to the implanted device. The devices comprise a unique microarchitectural arrangement in the sensor region that allows accurate data to be obtained over long periods of time.
    Type: Application
    Filed: April 19, 2010
    Publication date: August 12, 2010
    Applicant: DexCom, Inc.
    Inventors: Mark C. Shults, Stuart J. Updike, Rathbun K. Rhodes
  • DEVICE AND METHOD FOR DETERMINING ANALYTE LEVELS
    Publication number: 20100204555
    Abstract: Devices and methods for determining analyte levels are described. The devices and methods allow for the implantation of analyte-monitoring devices, such as glucose monitoring devices, that result in the delivery of a dependable flow of blood to deliver sample to the implanted device. The devices comprise a unique microarchitectural arrangement in the sensor region that allows accurate data to be obtained over long periods of time.
    Type: Application
    Filed: April 19, 2010
    Publication date: August 12, 2010
    Applicant: DexCom, Inc.
    Inventors: Mark C. Shults, Stuart J. Updike, Rathbun K. Rhodes
  • Low oxygen in vivo analyte sensor
    Patent number: 7771352
    Abstract: The present invention relates generally to systems and methods for measuring an analyte in a host. More particularly, the present invention relates to systems and methods for transcutaneous and subcutaneous measurement of glucose in a host.
    Type: Grant
    Filed: May 1, 2008
    Date of Patent: August 10, 2010
    Assignee: DexCom, Inc.
    Inventors: Mark C. Shults, Rathburn K. Rhodes, Stuart J. Updike, James H. Brauker
  • DEVICE AND METHOD FOR DETERMINING ANALYTE LEVELS
    Publication number: 20100160760
    Abstract: Devices and methods for determining analyte levels are described. The devices and methods allow for the implantation of analyte-monitoring devices, such as glucose monitoring devices that result in the delivery of a dependable flow of blood to deliver sample to the implanted device. The devices include unique architectural arrangement in the sensor region that allows accurate data to be obtained over long periods of time.
    Type: Application
    Filed: January 28, 2010
    Publication date: June 24, 2010
    Applicant: DexCom, Inc.
    Inventors: Mark C. Shults, Stuart J. Updike, Rathbun K. Rhodes, Barbara J. Gilligan, Mark A. Tapsak
  • Device and method for determining analyte levels
    Patent number: 7711402
    Abstract: Devices and methods for determining analyte levels are described. The devices and methods allow for the implantation of analyte-monitoring devices, such as glucose monitoring devices, that result in the delivery of a dependable flow of blood to deliver sample to the implanted device. The devices comprise a unique microarchitectural arrangement in the sensor region that allows accurate data to be obtained over long periods of time.
    Type: Grant
    Filed: December 22, 2004
    Date of Patent: May 4, 2010
    Assignee: DexCom, Inc.
    Inventors: Mark C. Shults, Stuart J. Updike, Rathbun K. Rhodes
  • DEVICE AND METHOD FOR DETERMINING ANALYTE LEVELS
    Publication number: 20100099970
    Abstract: Devices and methods for determining analyte levels are described. The devices and methods allow for the implantation of analyte-monitoring devices, such as glucose monitoring devices, that result in the delivery of a dependable flow of blood to deliver sample to the implanted device. The devices comprise a unique microarchitectural arrangement in the sensor region that allows accurate data to be obtained over long periods of time.
    Type: Application
    Filed: December 22, 2009
    Publication date: April 22, 2010
    Applicant: DexCom, Inc.
    Inventors: Mark C. Shults, Stuart J. Updike, Rathbun K. Rhodes